Terry P. Gould

Terry P. Gould discloses dealings in 4 companies, chiefly OncoMed Pharmaceuticals Inc, Aptinyx Inc. and Corvus Pharmaceuticals, Inc. In total, 106 filings cover trades dated from 23 July 2013 to 2 August 2021.

No open-market sale appears; the market trades are 19 purchases worth €10.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2021, the count stands at 4 purchases and no sales.

The median purchase comes to €535k. 19 out of 19 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 4 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -5.4%. This is a record of the past, not a forecast.

The latest filing, published on 3 August 2021, reports a transaction in Icosavax, Inc. The most recent open-market purchase was published on 3 August 2021, 1,923 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.